Sexual Function Post-Breast Cancer

Cancer Treat Res. 2018:173:167-189. doi: 10.1007/978-3-319-70197-4_11.

Abstract

The consequences of estrogen deprivation and therapeutic interventions such as radiation, chemotherapy and surgery have a significant negative impact on libido, sexual arousal, orgasmic function and the ability to have pleasurable intercourse. Evaluation and treatment of female sexual dysfunction is a significant unmet need in the breast cancer survivor in spite of the availability of safe and effective treatments.

Keywords: DHEA; Dyspareunia; Female sexual dysfunction; Fractional CO2 laser; Genitourinary syndrome of menopause; Hypoactive sexual desire disorder; Ospemifene; Prasterone; Vaginal estrogen.

Publication types

  • Review

MeSH terms

  • Administration, Intravaginal
  • Breast Neoplasms / psychology*
  • Breast Neoplasms / therapy
  • Estrogens / administration & dosage
  • Female
  • Humans
  • Lasers, Gas / therapeutic use
  • Sexual Behavior*
  • Testosterone / therapeutic use

Substances

  • Estrogens
  • Testosterone